C57BL/6-Il1btm1c(EUCOMM)Wtsi/H

Status

Available to order

EMMA IDEM:15920
Citation informationRRID:IMSR_EM:15920 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6-Il1btm1c(EUCOMM)Wtsi/H
Alternative nameinterleukin-1 beta conditional knockout
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolIl1btm1c(EUCOMM)Hmgu
Gene/Transgene symbolIl1b

Information from provider

ProviderEmmanuel Pinteaux
Provider affiliationUniversity of Manchester
Additional ownerEUCOMM ES cells used to produce this strain
Genetic informationIl1btm1a(EUCOMM)Hmgu embryonic stem cells were purchased from the European Mouse Mutant Cell Repository (EuMMCR). Cells from clone HEPD0840-8-E03 were cultured in KO-DMEM + KOSR + 2i (MEK inhibitor and GSK3 inhibitor) on a gelatin-coated cell culture dish maintained under standard culture conditions (37°C, 5% CO2, humidified). Cells were then microinjected into 4 to 8 cell B6N-Tyrc-Brd/BrdCrCrl embryos. Surviving embryos were surgically implanted into the oviduct of day 0.5 postcoitum pseudopregnant mice. Resulting black/white C57BL/6N chimeras were back-crossed onto C57BL/6N wild-type mice to assess germline penetrance. Potential founder mice were screened by PCR for LacZ, Neo and LoxP sites. This line was further crossed with C57BL/6N-Tg(CAG-Flpo)1Afst/Mmucd mice. The flp recombinase expression provided by this line resulted in a "conditional ready" (floxed) Il1btm1c(EUCOMM)Hmgu allele, in which exons 4 and 5 are flanked by loxP sites.
Phenotypic informationHomozygous:
No phenotype, as wild type

Heterozygous:
No phenotype, as wild type
Breeding historyBreeding as homozygous in standard cages
References
  • Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.;Helyes Zsuzsanna, Tékus Valéria, Szentes Nikolett, Pohóczky Krisztina, Botz Bálint, Kiss Tamás, Kemény Ágnes, Környei Zsuzsanna, Tóth Krisztina, Lénárt Nikolett, Ábrahám Hajnalka, Pinteaux Emmanuel, Francis Sheila, Sensi Serena, Dénes Ádám, Goebel Andreas, ;2019;Proceedings of the National Academy of Sciences of the United States of America;116;13067-13076; 31182576
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Literature references

  • Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.;Helyes Zsuzsanna, Tékus Valéria, Szentes Nikolett, Pohóczky Krisztina, Botz Bálint, Kiss Tamás, Kemény Ágnes, Környei Zsuzsanna, Tóth Krisztina, Lénárt Nikolett, Ábrahám Hajnalka, Pinteaux Emmanuel, Francis Sheila, Sensi Serena, Dénes Ádám, Goebel Andreas, ;2019;Proceedings of the National Academy of Sciences of the United States of America;116;13067-13076; 31182576

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).